Skip to content

EPS vs SPXV

WisdomTree U.S. LargeCap Fund

EPSANYSE Arca

ProShares S&P 500 Ex-Health Care ETF

SPXVBNYSE Arca

Overlap

Expense ratio

EPS −0.01pt a year

EPS0.08%SPXV0.09%

Avg volume · 30D

EPS 79.4×the volume

EPS51KSPXV642

10Y return · a year

SPXV +0.9pt

EPS+14.6%SPXV+15.5%

EPS vs SPXV Performance

Oct 29, 2021 – Oct 30, 2026

+75.9%EPS+79.4%SPXV

Oct 29, 2021 to Oct 30, 2026. EPS +75.9%. SPXV +79.4%. Use the arrow keys to read each point.−20%0%20%40%Oct 2021Apr 2024Oct 2026
Expense ratio
EPS 0.08%, better
SPXV 0.09%
Fund size
EPS $1.63B
SPXV $40M
1Y total return
EPS +14.0%, better
SPXV +10.0%
Yield (12M)
EPS 1.13%, better
SPXV 0.93%
Holdings
EPS 506
SPXV 443
Avg volume (30D)
EPS 51K sh, better
SPXV 642 sh
NAV per share
EPS $78.98
SPXV $81.83
52W range

ETF.net Grade

EPS: Cost 82, Risk 63, Mission 100, Tradability 84, Holdings 56, Durability 73. SPXV: Cost 73, Risk 38, Mission 95, Tradability 33, Holdings 45, Durability 60.
Pillar letters and Scores for EPS, SPXV, with each pillar’s weight
PillarEPSSPXV
Cost30% weightA82HigherA73
Mission25% weightA100HigherA95
Risk15% weightB63HigherD38
Tradability15% weightA84HigherD33
Holdings10% weightB56HigherC45
Durability5% weightA73HigherB60

Rank among US Large-Cap funds

Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. EPS and SPXV are both graded against the same 29 US Large-Cap funds, so their Grades compare head to head.

US Large-Cap⁠

Category · 29 funds
See all 29 ›

EPS ranks 3rd and SPXV 12th of 29 funds in the US Large-Cap Category.

  1. Rank 1ASCHXSchwab U.S. Large-Cap ETFScore 83
  2. Rank 2ABKLCBNY Mellon US Large Cap Core Equity ETFScore 82
  3. Rank 3AEPSWisdomTree U.S. LargeCap FundScore 80
  4. Rank 4AVVVanguard Morningstar Large-Cap ETFScore 78
  5. Rank 12BIQSUNYLI Candriam U.S. Large Cap Equity ETFScore 63
  6. Rank 12BSPXVProShares S&P 500 Ex-Health Care ETFScore 63
  7. Rank 14BXLGInvesco S&P 500 Top 50 ETFScore 61

Our read on each fund

ETF.net Research

EPSAWisdomTree U.S. LargeCap Fund

SPXVBProShares S&P 500 Ex-Health Care ETF

In short

EPS Large-cap core with a profit filter. Roughly 500 U.S. companies, all of them earnings generators, tracked since 2007 for 0.08% a year. Same plumbing as a plain index fund, with a screen most of them skip.

SPXV The S&P 500 with one sector surgically removed. SPXV holds roughly 400 large caps and leaves health care out, built for portfolios that already get their pharma and hospital exposure elsewhere.

Stated mandate

EPS The fund seeks to track earnings-generating large-cap companies in the U.S. equity market.

SPXV The Fund seeks investment results that track the performance of the S&P 500 Ex-Health Care Index before fees and expenses.

Why people hold it

  • EPS The screen is the whole point: the index holds large U.S. companies that actually generate earnings, so unprofitable names do not ride in on market cap alone.wisdomtree.com
  • 0.08% a year, under the median for its large-cap peer group, and it still spreads across roughly 500 stocks.
  • Running since 2007 and now a multi-billion-dollar fund, it has tracked its index tightly and ranks in the top quartile of its large-cap cohort.
  • Pays out quarterly, the standard cadence for a core equity holding.
  • SPXV Charges 0.09% a year, below the typical fund in its large-cap group.
  • One job, done tightly: it has hugged the S&P 500 Ex-Health Care Index closely instead of drifting from its stated mandate.
  • Saves the DIY work. Roughly 400 S&P 500 names in one ticker, with no screening or rebalancing on your end.
  • Trading since 2015, a long run for a single-sector carve-out, and it sits in the upper half of its large-cap peer group.

Worth knowing

  • EPS It trades thinly for the category, so bid-ask spreads can run wider than the heavily traded core names in the group.
  • Cheaper shelf-mates exist: SCHX and VV charge 0.03%, BKLC charges nothing. The earnings screen is what the extra basis points buy.
  • Screening on earnings means the portfolio can look different from a plain cap-weighted large-cap index, and its results will drift from that benchmark in both directions.
  • SPXV Thinly traded with a small asset base, so spreads can run wider than on a mainstream S&P 500 fund.
  • Pull a sector out and the rest weigh more. This tracks its own index, so it parts ways with the S&P 500 whenever health care moves differently.
  • Plain large-cap trackers such as SCHX and VV run 0.03%, so the sector carve-out carries a modest premium.

Full EPS profile⁠

Full SPXV profile⁠

EPS vs SPXV Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

EPS vs SPXV Cost

Overpaying SPXV vs EPS

$209

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • EPS 0.08%

    $1,689

  • SPXV 0.09%

    $1,898

$10,000
30 years

Cost over time

  • EPS 0.08%
  • SPXV 0.09%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$500$1K$1.5K$2K051015202530SPXV $1,898EPS $1,689

Year by year

YearEPSSPXVOverpaying
10$147$165$18
20$575$646$71
30$1,689$1,898$209

Expense ratio

  • 0.08%EPS, cheaper
  • 0.09%SPXV
  • Middle half of US Large-Cap funds
  • Median 0.20%

EPS 6th cheapest of 29 funds

SPXV 7th cheapest of 29 funds

EPS vs SPXV Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
EPS 1.13%, better
SPXV 0.93%
Payout (12M)
EPS $0.90
SPXV $0.76
Last payment
EPS $0.23
SPXV $0.18
Ex-dividend
EPS Sep 25, 2026
SPXV Sep 23, 2026
Paid on
EPS Sep 29, 2026
SPXV Sep 29, 2026
Frequency
EPS Quarterly
SPXV Quarterly

Distribution history

Per share, 2017 to 2026, same scale for both

EPSQuarterly · 39 paymentsAll EPS payments⁠
One bar per payment. 39 payments from 2017 to 2026 YTD. Mar 27, 2017 $0.11; Jun 26, 2017 $0.12; Sep 26, 2017 $0.13; Dec 26, 2017 $0.14; Mar 20, 2018 $0.10; Jun 25, 2018 $0.15; Sep 25, 2018 $0.16; Dec 24, 2018 $0.16; Mar 26, 2019 $0.13; Jun 24, 2019 $0.16; Sep 24, 2019 $0.18; Dec 23, 2019 $0.16; Mar 24, 2020 $0.18; Jun 23, 2020 $0.19; Sep 22, 2020 $0.18; Dec 21, 2020 $0.20; Mar 25, 2021 $0.17; Jun 24, 2021 $0.19; Sep 24, 2021 $0.19; Dec 27, 2021 $0.22; Mar 25, 2022 $0.17; Jun 24, 2022 $0.21; Sep 26, 2022 $0.22; Dec 23, 2022 $0.22; Mar 27, 2023 $0.19; Jun 26, 2023 $0.22; Sep 25, 2023 $0.22; Dec 22, 2023 $0.24; Mar 22, 2024 $0.21; Jun 25, 2024 $0.23; Sep 25, 2024 $0.22; Dec 26, 2024 $0.25; Mar 26, 2025 $0.20; Jun 25, 2025 $0.23; Sep 25, 2025 $0.23; Dec 26, 2025 $0.25; Mar 26, 2026 $0.20; Jun 25, 2026 $0.23; Sep 25, 2026 $0.23. Use the arrow keys to read each point.$0$0.252017202020232026YTD
SPXVQuarterly · 39 paymentsAll SPXV payments⁠
One bar per payment. 39 payments from 2017 to 2026 YTD. Mar 22, 2017 $0.10; Jun 21, 2017 $0.07; Sep 27, 2017 $0.14; Dec 26, 2017 $0.12; Mar 21, 2018 $0.10; Jun 20, 2018 $0.12; Sep 26, 2018 $0.13; Dec 26, 2018 $0.14; Mar 20, 2019 $0.11; Jun 25, 2019 $0.14; Sep 25, 2019 $0.13; Dec 24, 2019 $0.15; Mar 25, 2020 $0.12; Jun 24, 2020 $0.18; Sep 23, 2020 $0.12; Dec 23, 2020 $0.14; Mar 23, 2021 $0.11; Jun 22, 2021 $0.19; Sep 22, 2021 $0.12; Dec 23, 2021 $0.15; Mar 23, 2022 $0.13; Jun 22, 2022 $0.15; Sep 21, 2022 $0.18; Dec 22, 2022 $0.19; Mar 22, 2023 $0.14; Jun 21, 2023 $0.11; Sep 20, 2023 $0.17; Dec 20, 2023 $0.22; Mar 20, 2024 $0.15; Jun 26, 2024 $0.19; Sep 25, 2024 $0.18; Dec 23, 2024 $0.20; Mar 26, 2025 $0.16; Jun 25, 2025 $0.17; Sep 24, 2025 $0.19; Dec 24, 2025 $0.20; Mar 25, 2026 $0.18; Jun 24, 2026 $0.19; Sep 23, 2026 $0.18. Use the arrow keys to read each point.$0$0.252017202020232026YTD

EPS vs SPXV Risk

Fall from peak · 5 years

  • EPS
  • SPXV
Oct 29, 2021 to Oct 30, 2026. Worst fall: SPXV −26.6% · Oct 2022. Use the arrow keys to read each point.−25%−20%−15%−10%−5%0%Oct 2021Apr 2024Oct 2026

Risk facts

VolatilityStd dev, 3 years
EPS 11.8%, betterSPXV 13.3%
Return per unit of riskSharpe ratio, 3 years
EPS 1.43, betterSPXV 1.38
Worst fallMax drawdown, 5 years
EPS −23.6%, betterSPXV −26.6%
Market sensitivityBeta, 5 years
EPS 0.96SPXV 1.07

Popular comparisons

  • EPSAvsSCHXA

    WisdomTree U.S. LargeCap Fund · Schwab U.S. Large-Cap ETF

    Expense ratio
    0.08% · 0.03%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • SPXVBvsSCHXA

    ProShares S&P 500 Ex-Health Care ETF · Schwab U.S. Large-Cap ETF

    Expense ratio
    0.09% · 0.03%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • EPSAvsBKLCA

    WisdomTree U.S. LargeCap Fund · BNY Mellon US Large Cap Core Equity ETF

    Expense ratio
    0.08% · 0.00%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • SPXVBvsBKLCA

    ProShares S&P 500 Ex-Health Care ETF · BNY Mellon US Large Cap Core Equity ETF

    Expense ratio
    0.09% · 0.00%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • EPSAvsVVA

    WisdomTree U.S. LargeCap Fund · Vanguard Morningstar Large-Cap ETF

    Expense ratio
    0.08% · 0.03%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • SPXVBvsVVA

    ProShares S&P 500 Ex-Health Care ETF · Vanguard Morningstar Large-Cap ETF

    Expense ratio
    0.09% · 0.03%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.